Nadav Sahar

Weizmann Institute of Science, Tel Aviv, Tel Aviv, Israel

Are you Nadav Sahar?

Claim your profile

Publications (1)9.67 Total impact

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Multidrug transporters are integral membrane proteins that use cellular energy to actively extrude antibiotics and other toxic compounds from cells. The multidrug/proton antiporter MdfA from Escherichia coli exchanges monovalent cationic substrates for protons with a stoichiometry of 1, meaning that it translocates only one proton per antiport cycle. This may explain why transport of divalent cationic drugs by MdfA is energetically unfavorable. Remarkably, however, we show that MdfA can be easily converted into a divalent cationic drug/≥ 2 proton-antiporter, either by random mutagenesis or by rational design. The results suggest that exchange of divalent cationi c drugs with two (or more) protons requires an additional acidic residue in the multidrug recognition pocket of MdfA. This outcome further illustrates the exceptional promiscuous capabilities of multidrug transporters.
    Proceedings of the National Academy of Sciences 07/2012; 109(31):12473-8. DOI:10.1073/pnas.1203632109 · 9.67 Impact Factor